Schedule 13G ownership disclosure
SYROS PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 87184Q107
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.5700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-21-001391
- Form type
- SC 13G
- Filer
- Sumitomo Mitsui Trust Group, Inc.
- CIK
- CIK 1475365
- Filed
- Feb 05, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership